<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151404">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01970189</url>
  </required_header>
  <id_info>
    <org_study_id>CTBR-017 (TRA114972)</org_study_id>
    <nct_id>NCT01970189</nct_id>
  </id_info>
  <brief_title>The International ITP Registry</brief_title>
  <official_title>A Multi-centre, Prospective Disease Registry for Adults Diagnosed With Primary Immune Thrombocytopenia (ITP) in International Countries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>South Eastern Sydney Local Health District</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>South Eastern Sydney Local Health District</source>
  <oversight_info>
    <authority>Australia: Human Research Ethics Committee</authority>
    <authority>Brazil: Ethics Committee</authority>
    <authority>Chile: Institutional Review Board</authority>
    <authority>Colombia: Institutional Review Board</authority>
    <authority>Lebanon: Institutional Review Board</authority>
    <authority>Lebanon: Ministry of Public Health</authority>
    <authority>Malaysia: Institutional Review Board</authority>
    <authority>Malaysia: Ministry of Health</authority>
    <authority>Singapore: Institutional Review Board</authority>
    <authority>South Korea: Institutional Review Board</authority>
    <authority>Taiwan: Institutional Review Board</authority>
    <authority>Thailand: Ethical Committee</authority>
    <authority>Turkey: Ethics Committee</authority>
    <authority>Turkey: Ministry of Health</authority>
    <authority>Uruguay: Comite de Etica</authority>
    <authority>Uruguay: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary immune thrombocytopenia (ITP) is an uncommon disease characterised by a low platelet
      count, which may cause the patient to have a higher risk or increased duration of bleeding.
      Individual hospitals only encounter a small number of ITP patients each year which makes it
      difficult to study this disease. By creating this disease registry, we will be able to build
      a more complete picture of ITP, including treatment practices, through collecting
      information about the condition from patients across several hospitals in several countries.
      Research of this kind will help future patients by providing doctors with information about
      ITP, and about how patients have been treated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an observational disease registry database for recently-diagnosed adult patients
      with primary ITP that aims to understand the natural history of this rare disease and
      disease management. Participating investigators will prospectively enter real-world patient
      data on their enrolled patients with a minimum of 2 years follow up.

      Data from this registry will be used to generate descriptive statistics on demographics,
      clinical characteristics including prevalence and incidence of co-morbidities, treatment
      patterns, and adverse outcomes (resulting from treatment or disease) on ITP patients on an
      annual basis.  The information will be generated at the national or combined-country level.
      Furthermore, each institution will have an access to its data and may choose to generate
      descriptive statistics for its specific institution on a more frequent, ad-hoc basis.  New
      research questions or questions addressing a subset of registry patients to take advantage
      of combined registry data will require a separate protocol and review by independent
      committees

      The focus of this protocol is on adults with primary ITP, however, in future there may be
      interest to expand the population to explore secondary ITP patients as well. Hence, this
      registry is built to allow for some optional preliminary information related to secondary
      ITP to be captured.

      Multi-site participation of this registry project will be rolled out in stages, and will be
      offered to centres with appropriate expertise. Pilot countries included Australia, Korea,
      Taiwan, Singapore, Malaysia, Japan, Thailand and Turkey and sites will be selected based on
      their potential research (interest, resources, and expected patient volume). Additional
      sites may be added in the future from countries in Asia Pacific, Middle East and Latin
      America. Japan has an independent national ITP registry run by the government, however
      voluntary participation of interested Japanese investigators in this database will be
      welcomed, therefore allowing comparison of data between Japanese and non-Japanese patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2011</start_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>24 Months</target_duration>
  <primary_outcome>
    <measure>Disease progression of ITP</measure>
    <time_frame>up to 24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>This will include response assessment to each treatment modality, incidence and characteristics of bleeding events, bone marrow results (if available), development of refractory ITP and effects of any medical intervention (whether beneficial or detrimental) in the overall severity of the disease, according to definitions described by the ITP International Working Group.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Thrombocytopenia</condition>
  <arm_group>
    <arm_group_label>Primary Immune Thrombocytopaenia</arm_group_label>
    <description>Recently-diagnosed (i.e. &lt; 6 months) primary ITP adult patients (≥ 18 years) characterized by platelet counts less than 100x109/L as defined by the International Working Group.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adults recently-diagnosed with primary ITP will be prospectively enrolled into the
        registry. In cases where prospective data collection is not possible from initial
        diagnosis, eg if sites see mainly referred patients, those patients with pre-existing ITP
        of no longer than 6 months duration since diagnosis will be allowed into the registry,
        provided they are still prospectively being followed up or under ongoing review /
        treatment at the participating institution.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Recently-diagnosed (i.e. &lt; 6 months) primary ITP adults patients (≥ 18 years)
             characterized by platelet counts less than 100x109/L as defined by the International
             Working Group1.

          2. Able to provide written consent for data to be included in the registry
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beng H Chong</last_name>
    <role>Study Chair</role>
    <affiliation>SESLHD</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Beng H Chong, Professor</last_name>
    <phone>+612 91133426</phone>
    <email>benghock.chong@sesiahs.health.nsw.gov.au</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sarah Davidson, BNurs</last_name>
    <phone>+612 9113 2446</phone>
    <email>sarah.davidson@sesiahs.health.nsw.gov.au</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Canberra Hospital</name>
      <address>
        <city>Canberra</city>
        <state>Australian Capital Territory</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philip Crispin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St George Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2217</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beng H Chong</last_name>
      <phone>+612 9113 3246</phone>
    </contact>
    <contact_backup>
      <last_name>Sarah Davidson</last_name>
      <phone>+612 9113 2446</phone>
    </contact_backup>
    <investigator>
      <last_name>Beng H Chong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Liverpool Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Harvey</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tim Brighton</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Concord Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ilona Cunningham</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Calvary Mater Newcastle</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michelle Gambrill</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Simon McRae</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Coordenacao de Hematologica</name>
      <address>
        <city>Rio</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claudia MAXIMO</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Concepcion</name>
      <address>
        <city>Concepcion</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Monica ROMERO</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital San Jose</name>
      <address>
        <city>Bogota</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria SOLANO</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Foscal</name>
      <address>
        <city>Busaramanga</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luis SALAZAR</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Oncologico de Antioquia</name>
      <address>
        <city>Medellin</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juan DUQUE</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul St Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jong Wook LEE</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin Seok KIM</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ASAN Medical Centre</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Je-Hwan LEE</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ji-hyeon KWON</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Centre</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun Ho JANG</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mubarak Alkabeer Hospital</name>
      <address>
        <city>Kuwait City</city>
        <country>Kuwait</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajaa MAROUF</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sime Darby Medical Centre</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soo Chin NG</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ampang Hospital</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Singapore General Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lai Heng LEE</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr Liu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tan Tock Seng Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ponnudurai Kuperan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Taipei Veteran's General Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tzeon-Jye Chiou</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mackay Memorial Hospital</name>
      <address>
        <city>Taiwan</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yi-Fang CHANG</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>China Medical University Hospital</name>
      <address>
        <city>TAiwan</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li Yaun BAI</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Cheng Kung University Hospital</name>
      <address>
        <city>Taiwan</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tsai-Yun CHEN</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Taichung Veteran's General Hospital</name>
      <address>
        <city>Taiwean</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wen Li HWANG</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Siriraj Hospital</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yinyong CHINTHAMMITR</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ramathibodi Hospital</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pantep ANGCHAISUKSIRI</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chiang Mai University</name>
      <address>
        <city>Chiang Mai</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weerasak NAWARAWONG</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chulalongkorn University</name>
      <address>
        <city>Thailand</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pollapat ROJNUCKARIN</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pramongkutlao College of MEdicine</name>
      <address>
        <city>Thailand</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tontanai NUMBENJAPON</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ankara University</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Osman ILHAN</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Uruguay Society of Haematology</name>
      <address>
        <city>Uruguay</city>
        <country>Uruguay</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>TBA TBA</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Brazil</country>
    <country>Chile</country>
    <country>Colombia</country>
    <country>Korea, Republic of</country>
    <country>Kuwait</country>
    <country>Malaysia</country>
    <country>Singapore</country>
    <country>Taiwan</country>
    <country>Thailand</country>
    <country>Turkey</country>
    <country>Uruguay</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 22, 2013</lastchanged_date>
  <firstreceived_date>September 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Immune Thrombocytopenia</keyword>
  <keyword>Primary Immune Thrombocytopenia</keyword>
  <keyword>Purpura, Thrombocytopenic, Idiopathic</keyword>
  <keyword>Autoimmune Thrombocytopenia</keyword>
  <keyword>Thrombocytopenia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Thrombocytopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
